| 0 (0%) | 04-19 04:51 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.32 | 1-year : | 10.88 |
| Resists | First : | 7.98 | Second : | 9.32 |
| Pivot price | 7.16  |
|||
| Supports | First : | 6.97  |
Second : | 6.35 |
| MAs | MA(5) : | 7.12 |
MA(20) : | 7.14 |
| MA(100) : | 7.83 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 36.3 |
D(3) : | 34.2 |
| RSI | RSI(14): 52.3 | |||
| 52-week | High : | 10 | Low : | 4.76 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ GMBLP ] has closed below upper band by 44.8%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 7.29 - 7.32 | 7.32 - 7.35 |
| Low: | 6.47 - 6.51 | 6.51 - 6.55 |
| Close: | 7.13 - 7.21 | 7.21 - 7.27 |
Thu, 21 Dec 2023
The 10 Guiding Principles Of GMLP Identified By The FDA HC And MHRA - Med Device Online
Thu, 26 Oct 2023
Regulators agree to AI/ML PCCP guiding principles - Regulatory Focus
Tue, 24 Oct 2023
Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Guiding Principles - FDA.gov
Wed, 27 Sep 2023
Teachers on mission to educate Class 3 student with cerebral palsy - The New Indian Express
Thu, 17 Mar 2022
Meta AI’s Sparse All-MLP Model Doubles Training Efficiency Compared to Transformers - Synced
Thu, 28 Oct 2021
FDA releases 'guiding principles' for AI/ML device development - Healthcare IT News
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 1 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.38 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.34 |
| Profit Margin | -115.6 % |
| Operating Margin | -73.8 % |
| Return on Assets (ttm) | -27.8 % |
| Return on Equity (ttm) | -145.7 % |
| Qtrly Rev. Growth | 515.2 % |
| Gross Profit (p.s.) | 380.95 |
| Sales Per Share | 4.51644e+007 |
| EBITDA (p.s.) | 1.22192e+007 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -20 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -5.22 |
| PEG Ratio | 0 |
| Price to Book value | 2.14 |
| Price to Sales | 0 |
| Price to Cash Flow | -0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2022-03-30 |
| Ex-Dividend Date | 2022-02-13 |
|
|
|
|
|
|
|
|
|